Cryo-Cell International, Inc. CCEL
AMEX
| 08/31/2026 | 05/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.62% | 1.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.62% | 1.21% | |||
| Cost of Revenue | -3.79% | 1.22% | |||
| Gross Profit | 1.83% | 1.21% | |||
| SG&A Expenses | -18.17% | -7.86% | |||
| Depreciation & Amortization | 0.11% | 0.22% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.42% | -4.90% | |||
| Operating Income | 83.22% | 56.49% | |||
| Income Before Tax | 120.51% | 1,077.52% | |||
| Income Tax Expenses | 103.15% | 1,077.59% | |||
| Earnings from Continuing Operations | 129.08% | 1,077.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 129.08% | 1,077.49% | |||
| EBIT | 83.22% | 56.49% | |||
| EBITDA | 68.93% | 42.77% | |||
| EPS Basic | 129.07% | 1,086.21% | |||
| Normalized Basic EPS | 132.25% | 143.15% | |||
| EPS Diluted | 129.07% | 1,086.21% | |||
| Normalized Diluted EPS | 132.25% | 143.15% | |||
| Average Basic Shares Outstanding | 0.09% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.12% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||